Vaccine News and Research

Latest Vaccine News and Research

Existing anti-stroke drug can be effective in treating middle-ear infections

An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial clearance and reduce hearing loss, according to researchers at Georgia State University and the University of Rochester.

21 May 2015

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

In a report on what is believed to be the first small clinical trial of its kind, researchers at the Johns Hopkins Kimmel Cancer Center say they have safely used immune cells grown from patients' own bone marrow to treat multiple myeloma, a cancer of white blood cells.

21 May 2015

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced positive top-line data from a Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes.

21 May 2015

Stereotactic body radiotherapy appears to be safe, effective for some pancreatic cancer patients

Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose radiation treatment, called stereotactic body radiotherapy, appears to be safe and as effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread.

20 May 2015

Specific bacterial community in female genital tract induces inflammation, increases HIV risk

A team led by researchers from Massachusetts General Hospital and the Ragon Institute of MGH, MIT and Harvard has found that the most common bacterial community in the genital tract among healthy South Africa women not only is significantly different from that of women in developed countries but also leads to elevated levels of inflammatory proteins.

20 May 2015

Monash University researcher helps identify right type of Ebola vaccine trial

An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines.

20 May 2015

Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

Cryoport, Inc. today announced financial results for the three and twelve-month periods ended March 31, 2015.

19 May 2015

Pre-pregnancy maternal weight has significant impact on baby's immune system

Almost 60 percent of women of childbearing age in the United States are overweight or obese. Obesity is a major public health issue, and has been linked to health problems like heart disease, cancer and hypertension. It can complicate pregnancy by increasing the mother's risk of having gestational diabetes, preeclampsia, preterm birth or a baby with birth defects. Maternal obesity is also linked to several adverse health outcomes for the infant that can persist into adulthood, such as type-2 diabetes, heart disease and mortality.

19 May 2015

CMO Council announces the launch of global innovation ecosystem to advance UNICEF’s work

The Chief Marketing Officer (CMO) Council today announced the launch of a global CauseTech.net community and portal site, which is part of a new private sector initiative to crowdsource breakthrough ideas, inventions, products, and emerging technologies that can advance the work done by the UNICEF Global Innovation Center worldwide.

18 May 2015

WHO Regional Office for the Eastern Mediterranean press release: WHO delivers additional medicines and medical supplies into Yemen

WHO is also providing a shipment of anti-malaria medicines from the Global Fund to Fight AIDS, Tuberculosis and Malaria sufficient for 44 950 treatment courses of malaria...

15 May 2015

Sheffield scientists to showcase novel medical discoveries during International Clinical Trials Day

WORLD-leading researchers and scientists from Sheffield Teaching Hospitals Foundation Trust and the University of Sheffield will be giving people in Sheffield and beyond a unique insight into how they can contribute to groundbreaking medical discoveries during International Clinical Trials Day (Wednesday 20 May 2015).

15 May 2015

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.

13 May 2015

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

A new vaccine has proven almost completely effective in preventing shingles (disease medical name: herpes zoster), an extremely painful nerve infection which affects a third of Australians; most over the age of 50...

13 May 2015

Soligenix, Emergent BioSolutions sign development agreement

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax drug substance protein antigen.

13 May 2015

Research paves way for development of individualized immunotherapy for treating cancer

Mainz-based researchers have made significant advances with regard to the development of individualized immunotherapy strategies for treating cancer. They have managed to identify the relevant genetic changes or mutations associated with various types of cancer and have determined their individual blueprints.

13 May 2015

Invectys begins INVAC-1 phase I clinical trial in cancer patients

Invectys announces today that it has initiated a phase I clinical trial of its immunotherapeutic drug candidate INVAC-1.

13 May 2015

Brooks Automation, BioCision recognized with ISBER’s prestigious award for CryoPod Carrier

The CryoPod Carrier, jointly developed by Brooks Automation, a global provider of automated sample storage systems for compound management and biorepositories, and BioCision, LLC, a leader in advanced biomaterial sample handling and standardization tools, has won the 2015 New Product of the Year award from the International Society for Biological and Environmental Repositories.

13 May 2015

DKSH supports Pfizer’s expansion to Laos

DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their businesses in Asia, has signed an agreement to provide marketing, sales, logistics, distribution, credit management and -collection services to Pfizer in Laos.

12 May 2015

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

The European Investment Bank (EIB), the world’s largest multilateral bank, today reaffirmed its firm commitment to respond to the Ebola pandemic. The Bank has provided a EUR 50 million loan to Bavarian Nordic, an international biopharmaceutical company, for accelerated development of an Ebola vaccine with long-term efficacy. The financing is also backing research into vaccines for treating other infectious diseases and multiple cancer indications.

12 May 2015

Health workers now have rapid test to detect presence of chikungunya virus within an hour

Scientists at a U.S. Army research center have modified an assay that tests whether or not a sample of mosquitoes harbors the virus responsible for the disease known as chikungunya (CHIKV), long a problem in the Old World tropics but recently established in the Americas.

12 May 2015

Vaccine News and Research

Latest Vaccine News and Research

Existing anti-stroke drug can be effective in treating middle-ear infections

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Stereotactic body radiotherapy appears to be safe, effective for some pancreatic cancer patients

Specific bacterial community in female genital tract induces inflammation, increases HIV risk

Monash University researcher helps identify right type of Ebola vaccine trial

Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

Pre-pregnancy maternal weight has significant impact on baby's immune system

CMO Council announces the launch of global innovation ecosystem to advance UNICEF’s work

WHO Regional Office for the Eastern Mediterranean press release: WHO delivers additional medicines and medical supplies into Yemen

Sheffield scientists to showcase novel medical discoveries during International Clinical Trials Day

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

Soligenix, Emergent BioSolutions sign development agreement

Research paves way for development of individualized immunotherapy for treating cancer

Invectys begins INVAC-1 phase I clinical trial in cancer patients

Brooks Automation, BioCision recognized with ISBER’s prestigious award for CryoPod Carrier

DKSH supports Pfizer’s expansion to Laos

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

Health workers now have rapid test to detect presence of chikungunya virus within an hour

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in